ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CEL Celadon Pharmaceuticals Plc

61.00
1.50 (2.52%)
22 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Celadon Pharmaceuticals Plc LSE:CEL London Ordinary Share GB00BDQYGP38 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.50 2.52% 61.00 57.00 65.00 61.00 59.50 59.50 12,246 14:00:11
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Investment Advice 149k -7.14M -0.1082 -5.64 39.26M

Rule 8.3 - Celsis International Plc

27/08/2009 7:00am

UK Regulatory


Celadon Pharmaceuticals (LSE:CEL)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Celadon Pharmaceuticals Charts.
 
TIDMCEL 
 
 

FORM 8.3

 

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE

 

(Rule 8.3 of the Takeover Code)

 

1.KEY INFORMATION

 
Name of person dealing(Note 1)   Arnhold and S. Bleichroeder Advisers, LLC 
=------------------------------------------------------------------------- 
Company dealt in                 Celsis International Plc 
=------------------------------------------------------------------------- 
Class of relevant security to    5p ordinary shares 
which the dealings being 
disclosed relate (Note 2) 
=------------------------------------------------------------------------- 
Date of dealing                  August 26, 2009 
=------------------------------------------------------------------------- 
 
 

2.INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 
                                       Long            Short 
=----------------------------------------------------------------- 
                                       Number   (%)    Number  (%) 
=----------------------------------------------------------------- 
(1) Relevant securities 
=----------------------------------------------------------------- 
(2) Derivatives (other than options)   525,000  2.40% 
=----------------------------------------------------------------- 
(3) Options and agreements to 
purchase/sell 
=----------------------------------------------------------------- 
Total                                  525,000  2.40% 
=----------------------------------------------------------------- 
 
 

(b)Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 
Class of relevant security:                   Long         Short 
=--------------------------------------------------------------------- 
                                              Number  (%)  Number  (%) 
=--------------------------------------------------------------------- 
(1) Relevant securities 
=--------------------------------------------------------------------- 
(2) Derivatives (other than options) 
=--------------------------------------------------------------------- 
(3) Options and agreements to purchase/sell 
=--------------------------------------------------------------------- 
Total 
=--------------------------------------------------------------------- 
 
 

(c)Rights to subscribe (Note 3)

 
Class of relevant security:   Details 
=------------------------------------ 
=------------------------------------ 
 
 

3.DEALINGS (Note 4)

 

(a)Purchases and sales

 
Purchase/sale   Number of securities  Price per unit(Note 5) 
=----------------------------------------------------------- 
=----------------------------------------------------------- 
 
 

(b)Derivatives transactions (other than options)

 
Product name,   Long/short(Note 6)  Number              Price per unit(Note 
e.g. CFD                            of securities(Note  5) 
                                    7) 
=-------------------------------------------------------------------------- 
CFD             Long                50,000              GBP 2.328488 
=-------------------------------------------------------------------------- 
 
 

(c)Options transactions in respect of existing securities

 

(i)Writing, selling, purchasing or varying

 
Product     Writing,      Number of   Exercise  Type,      Expiry  Option 
name,       selling,      securities  price     e.g.       Date    money 
e.g. call   purchasing,   to                    American,          paid/received 
option      varying etc.  which the             European           per unit 
                          option                etc.               (Note 5) 
                          relates 
                          (Note 7) 
=------------------------------------------------------------------------------- 
=------------------------------------------------------------------------------- 
 
 

(ii)Exercising

 
Product name, e.g. call option   Number of securities  Exercise price per 
                                                       unit(Note 5) 
=------------------------------------------------------------------------ 
=------------------------------------------------------------------------ 
 
 

(d)Other dealings (including new securities) (Note 4)

 
Nature of transaction(Note 8)    Details  Price per unit (if 
                                          applicable)(Note 
                                          5) 
=----------------------------------------------------------- 
=----------------------------------------------------------- 
 
 

4.OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 
Full details of any agreement, arrangement or understanding 
between the person disclosing and any other 
person relating to the  voting rights of any relevant 
securities under any option referred  to on 
this form or relating to the voting rights or future 
acquisition or disposal of any relevant securities 
to which any  derivative referred to on this form 
is referenced. If none, this  should be stated. 
=----------------------------------------------------------- 
None. 
=----------------------------------------------------------- 
 
 

Is a Supplemental Form 8 attached? (Note 9) YES/NO

 
Date of disclosure                                        August 26, 2009 
=------------------------------------------------------------------------ 
Contact name                                              W. Rubenstein 
=------------------------------------------------------------------------ 
Telephone number                                          (212) 698-3128 
=------------------------------------------------------------------------ 
If a connected EFM, name of offeree/offeror 
with which connected 
=------------------------------------------------------------------------ 
If a connected EFM, state nature of connection(Note 10) 
=------------------------------------------------------------------------ 
 
 

Notes

 

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

 
 
 
 

1 Year Celadon Pharmaceuticals Chart

1 Year Celadon Pharmaceuticals Chart

1 Month Celadon Pharmaceuticals Chart

1 Month Celadon Pharmaceuticals Chart